Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.68 |
| ▸ | ECE1 | P42892 | 8/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | MPO | P05164 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.63 |
| ▸ | LTA4H | P09960 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7422711 | 1.00 | ACE (0.68) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL29603940 | 1.00 | ACE (0.68) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL29603737 | 0.95 | ACE (0.62) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL29603579 | 0.95 | ACE (0.62) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL29975563 | 0.92 | ACE (0.64) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL9852039 | 0.92 | ACE (0.67) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL9852029 | 0.92 | ACE (0.67) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL5583839 | 0.92 | ACE (0.72) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL3359705 | 0.92 | ACE (0.72) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL11855463 | 0.92 | ACE (0.72) | ACEECE1KDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118731374-B | Method for predicting deposition net energy of growing pigs | 中国农业大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118731374-A | Method for predicting deposition net energy of growing pigs | 中国农业大学 | 2024-10-01 | — | — | CN | claimed |
| CN-116298308-A | Metabolite markers associated with TSC-RAML differential diagnosis and prognosis prediction, and related products and uses | 中国医学科学院北京协和医院 | 2023-06-23 | — | — | CN | claimed |
| CN-118731374-B | Method for predicting deposition net energy of growing pigs | 中国农业大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-118731374-B | Method for predicting deposition net energy of growing pigs | 中国农业大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-118731374-A | Method for predicting deposition net energy of growing pigs | 中国农业大学 | 2024-10-01 | — | — | CN | disclosed |
| CN-118731374-A | Method for predicting deposition net energy of growing pigs | 中国农业大学 | 2024-10-01 | — | — | CN | disclosed |
| CN-116338204-A | Application of plasma protein marker in differential diagnosis and prognosis prediction of renal vascular smooth muscle lipoma related to tuberous sclerosis | 中国医学科学院北京协和医院 | 2023-06-27 | — | — | CN | disclosed |
| CN-116298308-A | Metabolite markers associated with TSC-RAML differential diagnosis and prognosis prediction, and related products and uses | 中国医学科学院北京协和医院 | 2023-06-23 | — | — | CN | disclosed |
| US-20150065366-A1 | Biomarkers for Bladder Cancer and Methods Using the Same | METABOLON, INC. | 2015-03-05 | — | — | US | disclosed |
| US-20140343865-A1 | Biomarkers for Kidney Cancer and Methods Using the Same | METABOLON, INC. | 2014-11-20 | — | — | US | disclosed |
| EP-2788763-A2 | BIOMARKERS FOR KIDNEY CANCER AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2014-10-15 | — | — | EP | disclosed |
| EP-2776832-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2014-09-17 | — | — | EP | disclosed |
| WO-2013086365-A2 | BIOMARKERS FOR KIDNEY CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-06-13 | — | — | WO | disclosed |
| WO-2013070839-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-05-16 | — | — | WO | disclosed |
| CN-1135717-A | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides | RHONE POULENC RORER PHARMA (US) | 1996-11-13 | — | — | CN | disclosed |